Investigation of the Genetic Diseases in Infants With Unknown Cause of Death

NCT06060249 | Unknown

• 1 other identifier: SIDS2023
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Sudden infant death syndrome (SIDS) is a disease of an infant under one year of age, whose sudden death occurred unexpectedly, which the cause of death cannot be determined despite macro-autopsy, and toxicological, pathological and microbiological examinations. It is most common in babies aged 2-4 months. Although it cannot be attributed to a single cause, it is suggested that apnea/airway obstruction, abuse, developmental disorders, exposure to cigarette smoke, infections, toxic gases, metabolic diseases, and cardiac problems cause SIDS. It is known that genetic studies on SIDS are few and the literature reported so far is insufficient. On the other hand, as a result of rapid developments in genetic diagnosis methods, various genes associated with SIDS have been reported in recent studies. Most of the studies conducted include genetic studies aimed at investigating specific disease groups in SIDS. Although there are few studies on comprehensive investigation of genetic causes, potentially causative variants have been identified in 20% of cases where whole exome sequencing has been performed. In a study including perinatal deaths in which the reports of the Forensic Medicine Institute in our country were examined, 4% of the cases were reported as infant deaths of unknown cause. However, this study is only autopsy data and does not include metabolic and genetic examinations. For this reason, as far as we know, there is no information about the incidence of SIDS in our country. Based on this information, in our research, in the province of Ankara, the deaths of children under one year of age who died unexpectedly and suddenly were examined, autopsied, and toxicological examinations were performed on internal organ samples and body fluids taken during the autopsy by the Ankara Group Presidency of the Forensic Medicine Institute between 2018 and 2023. Genetic investigation of hereditary diseases that may lead to death of cases whose cause of death cannot be explained despite pathological and microbiological examinations will be carried out by the Whole Exome Sequencing (WES) method. The project will be carried out by researchers at Ankara University Faculty of Medicine and Forensic Medicine Institute Ankara Group Presidency. This research project was planned as a prospective, descriptive, open uncontrolled study. The duration of the project is foreseen as 12 months. Approval for our research was received from Ankara University

Conditions

Sudden Infant Death

Outcome Measures

Primary Outcomes (1)

• Genetic diseases have an important place among the causes of sudden infant death syndrome

  if a preventable cause of hereditary death is found, the families of children whose genetic cause or causes are determined are informed about the genetic disease or diseases detected, in order to prevent the occurrence of these diseases in the next pregnancy or in future generations or relatives

  1-2 years

Secondary Outcomes (1)

• Genetic diseases have an important place among the causes of sudden infant death

  5-10 years

Eligibility Criteria

• Age: 1 Day - 12 Months
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Probability Sample

Study Population

This research project was planned as a prospective, descriptive, open uncontrolled study. The duration of the project is foreseen as 12 months. Approval for our research was received from Ankara University Human Research Ethics Committee.

You may qualify if:

• Under one year of age, who died unexpectedly and suddenly, whose cause of death could not be determined despite the death examination, autopsy, toxicological, pathological and microbiological examinations carried out on the internal organ samples and body fluids taken during the autopsy by the Forensic Medicine Institute Ankara Group Presidency between 2018 and 2023.
• Witness blood samples taken during the autopsies of the patients will be evaluated, and peripheral blood samples of 100 patients, stored under appropriate conditions, will be transferred to the genetic laboratory for DNA isolation and genetic study.

You may not qualify if:

• Patients with findings indicating congenital structural anomalies or known genetic syndromes during autopsy will not be included in the study.

Sponsors & Collaborators

• Ankara University: lead

Study Sites (1)

Hatice Mutlu

Ankara, Not US Or Canada, 06790, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Sudden Infant Death

Condition Hierarchy (Ancestors)

Death, Sudden; Death; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Infant Death

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assoc Prof, MD

Study Record Dates

• First Submitted: September 23, 2023
• First Posted: September 29, 2023
• Study Start: September 1, 2023
• Primary Completion: December 31, 2024
• Study Completion: January 1, 2025
• Last Updated: September 29, 2023

Record last verified: 2023-09

Locations

TU (1)